ALT Graphic titled "VIP released an independent evidence review of respiratory virus immunizations." Includes logos of the Vaccine Integrity Project and CIDRAP. Text states, "Here's what the evidence found on the flu, COVID-19 and RSV immunizations." A rightward arrow is shown against a blue background with virus illustrations. CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The influenza review found: Among adults over 65, the flu vaccine increased protection against hospitalization by 31%.* Vaccine effectiveness was 80% against laboratory-confirmed influenza-associated deaths among infants and children aged 6 months to 17 years.** *according to an analysis of VISION Network data ** in a case-cohort analysis of national surveillance data over eight seasons (2016-2020, 2021-2025)" CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The COVID-19 review found: For adults over 65, vaccination cut the risk of COVID-related hospitalization by 53% in the 2025-26 respiratory virus season.  Maternal vaccination lowered the risk of emergency department and urgent care visits for pregnant women by 58% and to infants aged 0-2 months too with a vaccine effectiveness range of 50-54%. Vaccinated young children (9 months-4 years) saw a 76% reduction in COVID-related pediatric emergency department visits." CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT A graphic with an teal and blue ombre background. Microbe icons are in the background of the right hand side of the image. Text reads, "The RSV review found: For adults over 60, studies showed significant protection against hospitalization, with vaccine effectiveness ranging from 69%-83% within the same season as vaccination. Vaccination during pregnancy reduced the risk of RSV among vaccinees by 82% and also reduced the risk of RSV-associated hospitalization among infants born subsequently. The infant monoclonal antibody immunization nirsevimab reduced the risk of RSV-related hospitalization by 64%-93% within 6-12 months." CIDRAP and VIP logos are on the bottom of the graphic. A link to the VIP website is on the bottom right corner of the image.

ALT pregnant woman

ALT Nurse putting a bandaid on a child's upper arm

ALT A mother and father with daughter holding teddy bear

ALT display of open oysters

ALT ebola virus

ALT Person sitting at computer at an IT center

ALT Older man in hospital bed with medical equipment around him

ALT NIH building

ALT Woman in white shirt holding her stomach and bending forward

ALT A person holding pills in one hand and a glass of water in the other

ALT Young girl stands in doorway with bright tapestry behind her

ALT An illustration of measles infections.

ALT A baby cries while holding their arm over their mouth.

ALT Parent holding child's hand in hospital

ALT Pencil erasing text

ALT A poster with Ebola information taped on a tree in the Democratic Republic of Congo

ALT Aedes aegypti mosquito